---
title: "China CIFI Holdings: The creditors' meeting will be held on June 3"
description: "China CIFI Holdings: The creditors' meeting will be held on June 3"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/239215663.md"
published_at: "2025-05-07T23:42:00.000Z"
---

# China CIFI Holdings: The creditors' meeting will be held on June 3

China CIFI Holdings: The creditors' meeting will be held on June 3rd

### Related Stocks

- [00884.HK - CIFI HOLD GP](https://longbridge.com/en/quote/00884.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | [Link](https://longbridge.com/en/news/276024005.md) |
| U.S. Removes List Linking Alibaba, Baidu to China Military | The Pentagon added several Chinese companies, including Alibaba and Baidu, to its Section 1260H list, linking them to Ch | [Link](https://longbridge.com/en/news/275920712.md) |
| Beijing Haizhi Technology Announces Final Offer Price | Beijing Haizhi Technology Group Co Ltd:FINAL OFFER PRICE HK$27.06 PER H SHARE UNDER GLOBAL OFFERING | [Link](https://longbridge.com/en/news/275780031.md) |
| Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | [Link](https://longbridge.com/en/news/276056763.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/en/news/276051793.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.